4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the FDA since Dec. 1.

Advertisement

1. Admelog is a short-acting insulin used to control blood sugar levels in adults and children older than three after they consume food.

2. Ozempic is a once-weekly injection used to improve glycemic control in adults with Type 2 diabetes.

3. The Vercise Deep Brain Stimulation System is an implantable device that stimulates a region of the brain to treat some of the symptoms of Parkinson’s disease.

4. Ogivri is a biosimilar cancer drug approved to treat patients with breast or metastatic stomach cancer.

More articles on supply chain:
10 recent pharma layoffs
Sanofi urges Philippine government to lift suspension of its dengue vaccine
Medline to relocate supply distribution center in Maryland, triple its workforce

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.